Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130201020M |
| Application |
Cancer Marker |
The kit has been designed for the quantitative determination of Pepsinogen II (PG II) in human serum. The method can be used for samples over the range of 1.0-100.0 ng/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
Efficient High-Throughput TestingThe MAGLUMI PG II is engineered for demanding laboratory environments, effortlessly processing up to 200 samples per hour. This efficiency makes it ideal for busy healthcare settings and ensures timely results for clinicians and patients alike.
User-Friendly Automated OperationA 10.4-inch color touchscreen simplifies operation, while full automation-including automated calibration and cleaning-reduces operator workload. Advanced onboard features support easy maintenance and walk-away functionality for staff convenience.
Comprehensive Sample and Reagent HandlingCapable of handling serum, plasma, and whole blood samples, and accommodating up to 144 patient samples and 25 reagents simultaneously, the MAGLUMI PG II supports a wide menu of tests. Integrated barcode readers help streamline workflow and reduce error.
FAQ's of Snibe MAGLUMI PG II (CLIA):
Q: How does the MAGLUMI PG II enhance workflow efficiency in diagnostic labs?
A: The MAGLUMI PG II processes up to 200 tests per hour, supports batch loading of 144 samples, and features fully automated functions such as on-board calibration and cleaning. This high throughput and automation reduce manual handling and speed up result delivery, making laboratory operations more efficient.
Q: What types of samples can be analyzed using the Snibe MAGLUMI PG II?
A: This analyzer accommodates serum, plasma, and whole blood samples, giving laboratories flexibility in handling diverse clinical testing requirements.
Q: When can I expect the first result after starting a batch?
A: The first result from the MAGLUMI PG II is available in approximately 17 minutes, allowing rapid turnaround for urgent testing needs.
Q: Where is this analyzer typically installed and used?
A: The Snibe MAGLUMI PG II is designed for use in clinical laboratories, diagnostics centers, and large healthcare institutions where reliable and high-throughput immunoassay testing is required.
Q: What is the process for sample and reagent management with this analyzer?
A: Samples and reagents are loaded efficiently with integrated barcode readers for both, enabling accurate tracking and minimizing errors. The system is fully automated, from sample identification to result generation.
Q: How does the MAGLUMI PG II benefit laboratories in terms of maintenance and waste management?
A: The analyzer incorporates automated cleaning functions to minimize routine maintenance and features in-built waste liquid and solid management systems, ensuring a hygienic working environment and smooth instrument operation.
Q: What are the advantages of using enhanced chemiluminescence detection in this analyzer?
A: Enhanced chemiluminescence detection provides high accuracy (CV < 2%) and wide dynamic measurement range, contributing to reliable results for a broad range of immunoassays.